Search results
Results from the WOW.Com Content Network
The blood-derived hepatitis B vaccine was withdrawn from the marketplace in 1986, replaced by Maurice Hilleman's improved recombinant hepatitis B vaccine which was approved by the FDA on 23 July 1986. [17] [19] [62] It was the first human vaccine produced by recombinant DNA methods. [62]
Baruch Samuel Blumberg (July 28, 1925 – April 5, 2011), known as Barry Blumberg, was an American physician, geneticist, and co-recipient of the 1976 Nobel Prize in Physiology or Medicine (with Daniel Carleton Gajdusek), for his work on the hepatitis B virus while an investigator at the NIH and at the Fox Chase Cancer Center. [3]
DTaP-IPV-HepB vaccine is a combination vaccine whose generic name is diphtheria and tetanus toxoids and acellular pertussis adsorbed, hepatitis B (recombinant) and inactivated polio vaccine or DTaP-IPV-Hep B. [1] It protects against the infectious diseases diphtheria, tetanus, pertussis, poliomyelitis, and hepatitis B. [2] [3] [4]
For premium support please call: 800-290-4726 more ways to reach us
Millman's work with Baruch Blumberg helped lead to the creation of a test to detect hepatitis B. The test allowed blood banks to identify the hepatitis B virus in the blood of potential donors, thereby preventing the spread of the virus. Later research by the team led to a vaccine that is now commonly given to neonates (newborns). [1]
The Baruch S. Blumberg Institute was established in 2003 by the Hepatitis B Foundation to conduct focused biomedical research on hepatitis B. Originally known as the Institute of Hepatitis and Virus Research, it was renamed in 2013 to honor its late co-founder and discoverer of the hepatitis B virus, Baruch S. Blumberg.
Alleged link between hepatitis B vaccine and chronic fatigue syndrome.. Pub Med." in absolutely no way supports the claim that hepatitis B is linked to chronic fatigue syndrome. I am removing it from the inline citation. It talks of a study done on 69 people who had symptoms of CFS that had also had a Hep B vaccine in 1990.
Adjuvant System 04 or AS04 is a trade name for a combination of adjuvants used in various vaccine products by GlaxoSmithKline, [1] in particular the Fendrix [2] hepatitis B vaccine and Cervarix [3] human papillomavirus (HPV) vaccine. It consists of aluminium hydroxide and monophosphoryl lipid A (MPL).